Reperfusion
therapy, the standard treatment for acute
myocardial infarction, can trigger necrotic death of cardiomyocytes and provoke
ischemia/reperfusion (I/R) injury. However, signaling pathways that regulate cardiomyocyte
necrosis remain largely unknown. Our recent genome-wide RNAi screen has identified a potential
necrosis suppressor gene PRKAR1A, which encodes PKA regulatory subunit 1α (R1α). R1α is primarily known for regulating PKA activity by sequestering PKA catalytic subunits in the absence of cAMP. Here, we showed that depletion of R1α augmented cardiomyocyte
necrosis in vitro and in vivo, resulting in exaggerated myocardial I/R injury and contractile dysfunction. Mechanistically, R1α loss downregulated the Nrf2
antioxidant transcription factor and aggravated oxidative stress following I/R. Degradation of the endogenous Nrf2 inhibitor Keap1 through p62-dependent selective autophagy was blocked by R1α depletion. Phosphorylation of p62 at Ser349 by
mammalian target of rapamycin complex 1 (
mTORC1), a critical step in p62-Keap1 interaction, was induced by I/R, but diminished by R1α loss. Activation of PKA by
forskolin or
isoproterenol almost completely abolished
hydrogen-peroxide-induced p62 phosphorylation. In conclusion, R1α loss induces unrestrained PKA activation and impairs the mTORC1-p62-Keap1-Nrf2
antioxidant defense system, leading to aggravated oxidative stress,
necrosis, and myocardial I/R injury. Our findings uncover a novel role of PKA in oxidative stress and
necrosis, which may be exploited to develop new cardioprotective
therapies.